Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B, Lingvay I, Thomsen M, Wadden TA, Wharton S, Wilding JPH, Rubino D
Although AOM liraglutide (Saxenda) has been approved for treatment of obesity in adolescents since late 2020 ( 5 ), the approval of AOM semaglutide (Wegovy) in December 2022 for treatment of obesity for adolescents prompted new excitement ( 6 )
Highly processed foods: Packaged snacks, fast food, and ready meals often contain excess salt, sugar, and unhealthy fats
If the redness persists unusually long or is accompanied by other symptoms, its advisable to consult a healthcare professional
Pregnancy and breastfeeding are clear reasons to wait
Tirzepatide adds the metabolic benefits of GIP activation , which may help the body process sugar and fat even more efficiently